NO150281C - Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 3,4,5,6-tetrahydro(1,3)thiazolo(3,4-a)isokinolinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 3,4,5,6-tetrahydro(1,3)thiazolo(3,4-a)isokinolinderivater

Info

Publication number
NO150281C
NO150281C NO741939A NO741939A NO150281C NO 150281 C NO150281 C NO 150281C NO 741939 A NO741939 A NO 741939A NO 741939 A NO741939 A NO 741939A NO 150281 C NO150281 C NO 150281C
Authority
NO
Norway
Prior art keywords
isoqinoline
thiazolo
tetrahydro
derivatives
preparation
Prior art date
Application number
NO741939A
Other languages
English (en)
Norwegian (no)
Other versions
NO741939A (no
NO150281B (no
Inventor
Kalman Harsanyi
Kalman Takacs
Pal Kiss
Laszlo Szekeres
Gyula Papp
Eva Benedek
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO741939A publication Critical patent/NO741939A/no
Publication of NO150281B publication Critical patent/NO150281B/no
Publication of NO150281C publication Critical patent/NO150281C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO741939A 1973-05-30 1974-05-29 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 3,4,5,6-tetrahydro(1,3)thiazolo(3,4-a)isokinolinderivater NO150281C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1381A HU170680B (hu) 1973-05-30 1973-05-30

Publications (3)

Publication Number Publication Date
NO741939A NO741939A (no) 1974-12-03
NO150281B NO150281B (no) 1984-06-12
NO150281C true NO150281C (no) 1984-09-19

Family

ID=10994482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO741939A NO150281C (no) 1973-05-30 1974-05-29 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 3,4,5,6-tetrahydro(1,3)thiazolo(3,4-a)isokinolinderivater

Country Status (24)

Country Link
US (1) US3979397A (hu)
JP (3) JPS6014038B2 (hu)
AR (1) AR213611A1 (hu)
AT (1) AT349018B (hu)
BE (1) BE815679A (hu)
BG (1) BG22391A3 (hu)
CA (1) CA1037042A (hu)
CH (2) CH622807A5 (hu)
CS (2) CS226901B1 (hu)
DD (1) DD119595A5 (hu)
DE (1) DE2426267C2 (hu)
DK (1) DK151028C (hu)
EG (1) EG11439A (hu)
ES (1) ES426773A1 (hu)
FI (1) FI57262C (hu)
FR (1) FR2241309B1 (hu)
HU (1) HU170680B (hu)
IL (1) IL44895A (hu)
NL (1) NL176944C (hu)
NO (1) NO150281C (hu)
PL (1) PL101194B1 (hu)
SE (1) SE419647B (hu)
SU (1) SU569291A3 (hu)
YU (1) YU37172B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062850A (en) * 1973-05-30 1977-12-13 Chinoin Pharmaceutical And Chemical Works Ltd. Thiazoloisoquinolines with coronary and respiratory effects
US4163786A (en) * 1973-05-30 1979-08-07 Chinoin Pharmaceutical And Chemical Works Ltd. Thiazoloisoquinolines with coronary and respiratory effects
NL169076C (nl) * 1975-08-06 1982-06-01 Rhone Poulenc Ind Werkwijze voor het bereiden of vervaardigen van farmacologische preparaten met een analgetische en antipyretische werking, alsmede werkwijze voor het bereiden van geneeskrachtige verbindingen, welke geschikt zijn voor gebruik in dergelijke preparaten.
US4108999A (en) * 1977-02-22 1978-08-22 Rhone-Poulenc Industries Thiazolo[3,4-b]isoquinoline derivatives, pharmaceutical compositions containing them and pharmaceutical methods using them
NL7908655A (nl) * 1978-12-07 1980-06-10 Rhone Poulenc Ind Nieuwe thienopyridine-derivaten, de bereiding ervan, alsmede farmaceutische preparaten, die de nieuwe derivaten bevatten.
HU178454B (en) * 1979-07-02 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new isoquinoline derivatives containing sulphur
JPH0332569Y2 (hu) * 1986-05-27 1991-07-10

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042671A (en) * 1959-10-07 1962-07-03 Pfizer & Co C Benzopyridocolines
US3455933A (en) * 1966-11-15 1969-07-15 American Home Prod Thiazolo and thiazino isoquinoline derivatives
US3665007A (en) * 1970-05-04 1972-05-23 Squibb & Sons Inc Thiazolo (3,4-a) benzimidazoles and derivatives thereof

Also Published As

Publication number Publication date
IL44895A0 (en) 1974-07-31
CA1037042A (en) 1978-08-22
NO741939A (no) 1974-12-03
YU37172B (en) 1984-08-31
CH622807A5 (hu) 1981-04-30
YU148074A (en) 1982-06-18
DE2426267A1 (de) 1975-01-09
IL44895A (en) 1979-07-25
BE815679A (fr) 1974-09-16
PL101194B1 (pl) 1978-12-30
EG11439A (en) 1978-12-31
FI164474A (hu) 1974-12-01
NO150281B (no) 1984-06-12
ATA433674A (de) 1978-08-15
CH620220A5 (hu) 1980-11-14
SE7407049L (hu) 1974-12-02
BG22391A3 (hu) 1977-02-20
JPS5047999A (hu) 1975-04-28
AT349018B (de) 1979-03-12
DE2426267C2 (de) 1984-02-09
FR2241309B1 (hu) 1977-11-04
JPS591714B2 (ja) 1984-01-13
JPS57145885A (en) 1982-09-09
FI57262B (fi) 1980-03-31
AR213611A1 (es) 1979-02-28
NL176944B (nl) 1985-02-01
FI57262C (fi) 1980-07-10
FR2241309A1 (hu) 1975-03-21
NL176944C (nl) 1985-07-01
DK289774A (hu) 1975-01-20
DK151028C (da) 1988-03-14
JPS6014038B2 (ja) 1985-04-11
US3979397A (en) 1976-09-07
NL7407280A (hu) 1974-12-03
HU170680B (hu) 1977-08-28
CS226901B1 (en) 1984-04-16
DD119595A5 (hu) 1976-05-05
JPS57145884A (en) 1982-09-09
ES426773A1 (es) 1976-07-16
SU569291A3 (ru) 1977-08-15
JPS5842195B2 (ja) 1983-09-17
DK151028B (da) 1987-10-12
CS227001B2 (en) 1984-04-16
SE419647B (sv) 1981-08-17

Similar Documents

Publication Publication Date Title
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
NO143846C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
SE424324B (sv) Analogiforfarande for framstellning av 1,2-benzisoxazolderivat
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO146396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO142865C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO143223C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO143943C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 3-(4-p-fluorfenyl-1-metylbutyl)-1-hydroksy-6,6,9-trimetyl-7,8,9,10-tetrahydro-6h-dibenzo(b,d)pyran
NO150882C (no) Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater
NO141649C (no) Analogifremgangsmaate for fremstilling av neuroleptisk aktive 7-fluorsubstituerte fenotiaziner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO142625C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater
NO150281C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 3,4,5,6-tetrahydro(1,3)thiazolo(3,4-a)isokinolinderivater
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO141160C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3,4-dihydro-2(1h)-isokinolinkarboksamider
FI55659C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 3-(4-substituerad-piperazin-1-ylkarbonyloxi)-2-(1,8-naftyridin-2-yl)isoindolin-1-oner
NO140858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 2,4-diamino-5-benzyl-pyrimidinderivater
NO144457C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner
NO141441C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater